Agilent Technologies has introduced three new models in its Dako Omnis line of staining instruments, designed to support ...

From immunotherapy to targeted agents, learn how innovative strategies are redefining outcomes in early-stage triple-negative ...

The oncology companion diagnostic market is projected to grow at a CAGR of ~10% over the forecast period. The market is driven by the growing adoption of precision medicine, rising cancer incidence, ...

Researchers tested more than 65,000 patients with more than 30 solid tumor types and found the rate of HER2 positivity was about 3%.

Agilent Technologies Inc. (NYSE: A) today announced the introduction of its Dako Omnis family of instruments with three new ...